Latest Jazz Pharmaceuticals plc Stories
Defitelio®? (defibrotide) Launch Announced During the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) 2014 DUBLIN and VILLA GUARDIA, Italy,
Chief Financial Officer Kathryn Falberg to Step Down; Matthew Young Appointed CFO DUBLIN, Feb.
Company Reports Total Revenues of $872 Million in 2013 Driven by Strong Sales of Xyrem and Erwinaze DUBLIN, Feb.
Approximately 98 percent of outstanding Gentium ordinary shares and American Depositary Shares tendered DUBLIN, Feb.
First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S.
Approximately 79 percent of outstanding Gentium ordinary shares and American Depositary Shares tendered DUBLIN, Jan.
Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments DUBLIN, Jan.
- A transitional zone between two communities containing the characteristic species of each.